Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3SBIO Inc | 83B | Jun 14, 2024 | 0.69 | 0.00 |
Acrux Ltd | FJY | Jun 14, 2024 | 0.04 | -2.30 |
Actinogen Medical Limited | 3AC | Jun 14, 2024 | 0.02 | 0.00 |
Akeso Inc | 4RY | Jun 14, 2024 | 4.56 | +0.44 |
Aligos Therapeutics, Inc. - Common stock | 5WK | Jun 14, 2024 | 0.46 | +0.22 |
Alphamab Oncology (HK) Limited | 3NK | Jun 14, 2024 | 0.28 | +0.72 |
Alterity Therapeutics Ltd | PBN | Jun 14, 2024 | 0.00 | 0.00 |
AnGes Inc. | AJW | Jun 14, 2024 | 0.21 | 0.00 |
Antengene Corporation Limited | 722 | Jun 14, 2024 | 0.08 | -3.09 |
Ascletis Pharma Inc. | 2VJ | Jun 14, 2024 | 0.12 | 0.00 |
Avacta Group Plc | RTQ1 | Jun 14, 2024 | 0.41 | -0.97 |
Avecho Biotechnology Limited | OEZ | Jun 14, 2024 | 0.00 | 0.00 |
BeiGene Ltd | 49B | Jun 14, 2024 | 11.60 | +0.87 |
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A. | 6NQ | Jun 14, 2024 | 1.05 | -0.75 |
Biophytis | 6XB | Jun 14, 2024 | 0.00 | 0.00 |
Biotest AG | BIO3 | Jun 14, 2024 | 25.70 | 0.00 |
Bioton S.A. | 7U5 | Jun 14, 2024 | 0.78 | -1.39 |
Bioventix Plc | 51B | Jun 14, 2024 | 49.00 | +2.51 |
Bone Therapeutics S.A. | BT1 | Jun 14, 2024 | 0.01 | -2.50 |
Cellectis | ZVA | Jun 14, 2024 | 2.06 | -5.49 |
Celon Pharma SA | 8RP | Jun 14, 2024 | 3.35 | -1.33 |
Chromadex Corp | OCD1 | Jun 14, 2024 | 2.94 | +6.52 |
Circassia Group Plc | 82C | Jun 14, 2024 | 0.78 | 0.00 |
CKLIFE SCIENCES | LSI | Jun 14, 2024 | 0.04 | +1.43 |
Clinuvel Pharmaceuticals Ltd | UR9A | Jun 14, 2024 | 8.85 | +0.57 |
Clinuvel Pharmaceuticals Ltd Ordinary Shares (Australia) | UR9 | Jun 14, 2024 | 9.10 | +2.30 |
Csl Ltd SPONSORED ADR (Australia) | CSJA | Jun 14, 2024 | 87.50 | +0.57 |
CSL Ltd. | CSJ | Jun 14, 2024 | 177.38 | +0.25 |
CSTONE PHARMAC. DL-,0001 | PH4 | Jun 14, 2024 | 0.12 | -0.81 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Jun 14, 2024 | 0.17 | -6.56 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.